Hongcheng Zhu, Radiation and Clinical Oncologist at Fudan University Shanghai Cancer Center, shared a post on X:
“Great to attend Anti-Cancer Drug Innovation and Research Development meeting 2025 and Speciality Committee meeting of PhIRDA. Innovation, industrialization and internationalization through academia-industry-investment collaboration exerts for anti-cancer therapies in China and beyond.”
More posts featuring Hongcheng Zhu.
